Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Medtronic
Mallinckrodt
AstraZeneca
Harvard Business School

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021669

See Plans and Pricing

« Back to Dashboard

NDA 021669 describes CHLORHEXIDINE GLUCONATE, which is a drug marketed by Sage Prods, Bajaj, Hi Tech Pharma, Lyne, Pharm Assoc, Wockhardt Bio Ag, Xttrium, Becton Dickinson, and Kendall Il, and is included in ten NDAs. It is available from thirty suppliers. There are five patents protecting this drug. Additional details are available on the CHLORHEXIDINE GLUCONATE profile page.

The generic ingredient in CHLORHEXIDINE GLUCONATE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 021669
Tradename:CHLORHEXIDINE GLUCONATE
Applicant:Sage Prods
Ingredient:chlorhexidine gluconate
Patents:5
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021669
Suppliers and Packaging for NDA: 021669
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669 NDA Sage Products LLC 53462-007 53462-007-27 1 KIT in 1 KIT (53462-007-27) * 1 BOTTLE in 1 KIT > 4 mL in 1 BOTTLE * 15 mL in 1 BOTTLE (53462-003-15) * 6 CLOTH in 1 PACKAGE (53462-705-23)
CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669 NDA Sage Products, LLC 53462-009 53462-009-24 1 KIT in 1 KIT (53462-009-24) * 7 mL in 1 PACKET (53462-375-60) * 6 PACKAGE in 1 KIT > 6 CLOTH in 1 PACKAGE (53462-705-23)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CLOTH;TOPICALStrength2%
Approval Date:Apr 25, 2005TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Feb 17, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:DISINFECTION OF PATIENT SKIN PRIOR TO AN INVASIVE PROCEDURE
Patent:  Start TrialPatent Expiration:Apr 25, 2026Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:May 12, 2023Product Flag?YSubstance Flag?Delist Request?
Patented Use:FOR THE PREPARATION OF SKIN PRIOR TO SURGERY; HELPS REDUCE BACTERIA THAT CAN POTENTIALLY CAUSE SKIN INFECTION

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.